| NO | PRODUCT NAME | FORM | PACKAGING | DESCRIPTION | COMPOSITION |  |  |
|---|---|---|---|---|---|---|---|
| 1 | CEPHANEXT | INJECTABLE | 1 powder vial & 1 solvent vial of 25 ml | HIGH CLINICAL EFFICACY in the TREATMENT of RESPIRATORY DISEASES, SEPTICAEMIAS MENINGITIS, PYODERMAS, MASTITIS, and METRITIS. | Cephalexin sodium 300 mg Chlorpheniramine maleate 10 mg Dexamethasone sodium phosphate 0.5 mg Excipient to 1 ml | ||
| 2 | CEFTINEXT 50 | INJECTABLE | 100ml and 250ml Vials | A semisynthetic, third-generation, broad-spectrum cephalosporin antibiotic, which is administered to cattle and swine for control of bacterial infections of the respiratory tract, with additional action against foot rot and acute metritis in cattle. It has a wide spectrum of activity against both Gram-positive and Gram-negative bacteria. It exerts its antibacterial action by inhibition of cell wall synthesis. Ceftiofur is mainly excreted in urine and feces. | Ceftiofur (hydrochloride) 50 mg Excipient to 1 ml | ||
| 3 | AMOXINEXT 10 | INJECTABLE | 100ml and 250ml Vials | A broad-spectrum semi-synthetic penicillin with bactericidal activity against a wide range of gram-positive and gram-negative bacteria including the following: Gram-negative: Actinobacillus lignieresi ; Bordetella bronchiseptica, Escherichia coli (non β lactamase producing strains), Corynebacterium spp.; Fusobacterium spp.; Haemophilus spp.; Moraxella spp.; Pasteurella spp.; Proteus mirabilis (non β-lactamase producing strains); Salmonella spp. Gram-positive: Bacillus anthracis; Clostridium spp.; Erysipelothrix rhusiopathiae ; streptococci; staphylococci (non β-lactamase producing strains). | Amoxicillin (trihydrate) 10 g Excipient to 100 m | ||
| 4 | OXYNEXT 10 | INJECTABLE | 50ml and 100ml Vials | A highly active, broad spectrum tetracycline antibiotic with bacteriostatic activity against a wide variety of gram-positive and gram-negative organisms. The product is specifically formulated to provide a prolonged action resulting in sustained antibacterial activity. | Oxytetracycline (Hydrochloride) 10g Excipient to 100ml | ||
| 5 | PENCINEXT 5m | INJECTABLE | 1 powder vial & 1 solvent vial of 25 ml | A bactericidal against penicillin-susceptible microorganisms. Streptomycin is an aminoglycoside antibiotic with bactericidal activity against both gram-negative and some gram-positive bacteria. Penicillins and aminoglycosides act synergistical. | Powder vial: Penicillin G sodium 1.250.000 I.U. Penicillin G procaine 3.750.000 I.U. Dihydrostreptomycin sulphate 3,125 g Streptomycin sulphate 3,125 g Solvent vial: Sterile solvent to 25 ml. | ||
| 6 | MACLONEXT 7.5 | INJECTABLE | 1 powder vial & 1 solvent vial of 25 ml | Pneumonia, broncho-pneumonia, intestinal infections, mastitis, conjunctivitis, cystitis, endometritis, furunculosis, leptospirosis, osteomyelitis, otitis, hemorrhagic septicaemia, cutaneous infections, infected wounds and erysipelas. | Powder vial: Metampicillin sodium 5 g Cloxacillin sodium 2,5 g. Solvent vial: Sterile solvent to 25 ml. | ||
| 7 | GENTANEXT 6 | INJECTABLE | 100ml and 250ml Vials | An antibiotic belonging to the group of amino-glycosides. It has bactericidal activity against Gram-positive and Gram-negative bacteria (including: Pseudomonas spp., Klebsiella spp., Enterobacter spp., Serratia spp., E. coli, Proteus spp., Salmonella spp., Staphylococci). Furthermore it is active against Campylobacter fetus subsp. jejuni and Treponema hyodysenteriae. Gentamycin may be active against bacteria which are resistant to other amino-glycoside antibiotics (like neomycin, streptomycin, and kanamycin). | Gentamicin (sulphate) 6 g Excipient to 100 ml | ||
| 8 | SULFANEXT 10 STL | INJECTABLE | 100ml and 250ml Vials | A combination of different active ingredients. It has a high antibacterial activity and is effective against many bacterial agents as: Haemophilus spp., Pasteurella spp., Streptococcus spp., Staphylococcus spp., Klebsiella spp., Proteus spp., E.coli, Salmonella spp., Nocardia spp., Corynebacterium spp., Bordetella spp. and Clostridium spp. | Sulfamethoxypyridazine sodium 10 g Trimethoprim 2 g Lincomycin (HCl) 2,7 g Spectinomycin(sulphate) 5,4 g Bromhexine 230 mg Guaiacol glyceryl ether 5 g Eucalyptol 1 g Chlorpheniramine maleate 300 mg Dexamethasone sodium phosphate 20 mg; Ephedrine HCl 500 mg; Excipient to 100 ml. | ||
| 9 | SPECLINEXT 15 | INJECTABLE | 100ml and 250ml Vials | The combination of lincomycin and spectinomycin has an additive mode of action, and in many cases acts synergistic. Lincomycin has a bacteriostatical mode of action against mainly Gram-positive bacteria (like Staphylococcus aureus, Streptococcus pyogenes, Str. suis, Str. agalactia, Diplococcus pneumonia, Corynebacterium pyogenes, Clostridium perfringens, Cl. tetani and Pasteurella multocida). Enterococci and Gram-negative bacteria are hardly sensitive. Anaerobe micro-organisms are very sensitive, like Bacteroides spp. and Fusibacterium spp. (Doyle-dysentery) and Mycoplasmas (like M. galli septicum, M. hyosynovia, M. meleagridis, M. canis and M. hyorhinis; M. pneumonia is hardly sensitive). | Spectinomycin (sulphate tetrahydrate) 100 mg Lincomycin (hydrochloride) 50 mg Excipient to 1 ml | ||
| 10 | SULFANEXT 20 | INJECTABLE | 50ml and 100ml Vials | Ovine and caprine: Bacterial pneumonia, Bovine: Foot infections, Bacterial pneumonia, Omphalitis. Colibacillosis, Pasteurellosis. Swine: Bacterial pneumonia, Colibacillosis, Atrophic rhinitis, Haemorrhagic septicaemia. Equine: Metritis, Bacterial pneumonia. Infections produced by the following sensitive germs: Corynebacterium spp. Gram (+): Clostridium perfrigens, Staphylococcus spp., Streptococcus spp. -Gram (-): Escherichia coli, Salmonella spp., Proteus spp., Haemophilus spp., Pasteurella multocida, Pasteurella haemolytica, Fusobacterium spp. - Protozoa: Eimeria spp. | Sulfamethoxypyridazine sodium 20g Excipient to 100 ml. | ||
| 11 | SULFANEXT 20 T | INJECTABLE | 100ml and 250ml Vials | The combination of trimethoprim and sulfamethoxazole acts synergistic and usually bactericidal against many Gram-positive and Gram-negative bacteria like E. coli, Haemophilus, Pasteurella, Salmonella, Staphylococcus and Streptococcus spp. Both compounds affect bacterial purine synthesis in a different way, as a result of which a double blockade is accomplished. | Sulfamethoxypiridazine 20 g Trimethoprim 4 g Excipient to 100 ml. | ||
| 12 | SULFANEXT 20 T2 | INJECTABLE | 100ml and 250ml Vials | Treatment of respiratory colibacillary problems. Very effective against a large number of causative agents of diseases (Streptococci, Staphylococci, Corynebacteria, etc.). | Tylosin 5 g Trimethoprim 4 g Sulfachloropyridazine 20 g Excipient to 100 ml. | ||
| 13 | CLOSANEXT | INJECTABLE | 100ml and 250ml Vials | Treatment and prevention of several infections caused by parasites sensitive for closantel like Fasciola hepatica, Fasciola gigantica, Haemonchus concortus, Haemonchus placei, Bunostomum phlebotomum, Oesophagostomum radiatum and Strongyloides papillosus in cattle and sheep. | Closantel 5 g Excipient to 100 ml | ||
| 14 | LEVANEXT 6 | INJECTABLE | 100ml and 250ml Vials | A synthetic anthelmintic with activity against a broad spectrum of gastrointestinal worms and lungworms. Levamisole causes an increase in the axial muscle tone followed by paralysis of worms. | levamisole (hydrochloride) 60 mg Excipient to 100 ml | ||
| 15 | DEXANEXT | INJECTABLE | 50ml and 100ml Vials | Dexamethasone is a synthetic glucocorticosteroid with an intermediate duration of activity. It exhibits potent antiphlogistic, anti-inflammatory, anti-allergic, immune-suppressive and gluconeogenetic actions. | Dexamethasone (sodium phosphate) 100 mg Excipient to 100 m | ||
| 16 | DEXANEXT PR | INJECTABLE | 50ml and 100ml Vials | A synthetic derivative of the glucocorticoid hydroxycortisone which has been used for many years in veterinary medicine. It is used in the treatment of metabolic diseases (e.g. ketosis) in ruminants, inflammatory diseases in a number of animal species and it also shows an antiallergic effect. The hydrosoluble salts are rapidly absorbed from the inoculation site, obtaining a maximum serum concentration within few minutes after subcutaneous or intramuscular administration. | Dexamethasone isonicotinate 100 mg Prednisolone 300 mg Excipient to 100 m | ||
| 17 | FLUNEXT | INJECTABLE | 100ml and 250ml Vials | A non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties. | Flunixin (meglumine) 50 mg Excipient to 1 m | ||
| 18 | PENTANEXT | INJECTABLE | 50ml 100ml Vials | Respiratory-cardiac tonic indicated in cases of collapse, faintness, weakness, tiredness, coma, post-operative period, dispnea syndromes, asphyxia, oedema, pulmonary congestion, asthma and other heart diseases which are present in some infectious diseases. | Pentamethylentetrazole 8 g Ephedrine hydrochloride 1 g Strophantin K 10 mg Excipient to 100 ml. | ||
| 19 | OXYTONEXT 1000 | INJECTABLE | 10ml 100ml 250ml Vials | A hormone, influencing uterine musculature in the late stage of pregnancy, during and a few days after parturition. It is used for speeding expulsion of the foetus or foetuses (only in dogs,cats and pigs), and after parturition it promotes the expulsion of the placenta and the involution of the uterus. Owing to its effect on myoepithelial cells around the alveoli of the udder, it stimulates and increases the secretion of milk. | Oxytocin (synthetic) 1000 IU Excipient to 100 ml | ||
| 20 | SPASMONEXT | INJECTABLE | 50ml and 100ml Vials | A unique dual-action formula: the antispasmodic effectiveness of Hyoscine Butylbromide combined with the proven analgesic properties of Metamizole. This special combination allows cramped muscles to relax and simultaneously delivers fast relief from pain associated with spasms. | Hyoscine (N-butyl bromide) 400 mg Metamizole 50 g Excipient to 100 ml | ||
| 21 | BCOMNEXT | INJECTABLE | 1 powder vial & 1 solvent vial of 50 ml | Essential in the metabolism of carbohydrates, proteins and lipids. It is also essential for the proper operation of numerous physiological functions. | Powder vial: Vitamin B1 1,25 g: Vitamin B6 0,25 g Vitamin B12 1 mg Biotin 1 mg Calcium pantothenate 1g. Solvent vial: Vitamin B2 0,10g Nicotinamide 5g Excipient to 50 ml. | ||
| 22 | IRONEXT 10 | INJECTABLE | 100ml Vial | Used for prophylactics and treatment of iron deficiency caused anaemia in piglets and calves. Parenteral administration of iron has the advantage that the necessary amount of iron can be administered in one single dosage. Cyanocobalamin is used for prophylactics and treatment of cyanocobalamin deficiency caused anaemia. | Iron-dextran 10g Excipient to 100ml | ||
| 23 | ULTRAFEED | INJECTABLE | 250 ml Vial | Treatment and prevention of stress conditions. Growth stimulant for bovine, ovine and swine. under-developed animals. As immunostimulation against infection. As an aid during gestation and lactation. In cases of convalescence, loss of appetite, hepatic failure and several illnesses. After vaccination and transport. | Aspartic acid 960 mg Threonine 320 mg Serine 480 mg Glutamic acid 1,40 g Glycine 810 mg Proline 760 mg Alanine 730 mg Cystine 40 mg Valine 280 mg Methionine 250 mg Isoleucine 250 mg Leucine 760 mg Tyrosine 340 mg Phenylalanine 340 mg Tryptophan 100 mg Lysine 500 mg Histidine 220 mg Arginine 270 mg Excipient to 100 ml | ||
| 24 | FOSVIROM | INJECTABLE | 100ml 250ml Vials | Constitutes a pharmaceutical speciality indicated to replace any imbalance of Calcium, Phosphorus and Magnesium, which are indispensable for keeping the physiological functions in good working order. It contains Vitamin D, whose main role is to regulate the Calcium and Phosphorus metabolism, as well as a vitamin B complex which stimulates the nervous function and takes part in the essential elements metabolism. | Sodium hypophosphite 3.25 g Calcium gluconate 18.6 g Magnesium oxide 0.6 g Dextrose 10 g Dexamethasone 21 P 2 mg Vitamin D3 20,000 IU Vitamin B1 100 mg Vitamin B6 30 mg Vitamin B12 100 gammas Protein hydrolysate 8.50 g Excipient to 100 ml | ||
| 25 | NEXTIUM | INJECTABLE | 500ML Vials | Dehydration states. Enteric processes with diarrhoea, together with the corresponding antiinfectious therapy. In general, whenever large losses of organic liquids occur. | Glucose 2,5 g Fructose 2,5 g Chloride 262 mg Sodium 157 mg Potassium 8 mg Magnesium 2 mg Calcium 4 mg Sterile water to 100 ml | ||
| 26 | GENTANEXT 4 | INJECTABLE | 100 ML | updating soon | Each ml contains: gentamicin (sulfate) 40 mg | ||
| 27 | TULANEXT 10 | INJECTABLE | 100 ML | updating soon | Each ml contains: tulathromycin 100 mg. | ||
| 28 | AMINEXT | INJECTABLE | 100 ML | updating soon | Each ml contains: lysine (hydrochloride) 52 mg; methionine 20 mg; threonine 10 mg; leucine 7.5 mg; valine 6 mg; isoleucine 4.5 mg. | ||
| 29 | CALNEXT GM | INJECTABLE | 100 ML | updating soon | Each ml contains: calcium gluconate monohydrate 170 mg; glucose (monohydrate) 90 mg; magnesium chloride hexahydrate 50 mg. | ||
| 30 | NEXT AD3E 450K | INJECTABLE | 100 ML | updating soon | Each ml contains: vitamin A 100,000 IU; vitamin D3 500,000 IU; vitamin E (all-rac-α-tocopheryl) 50 mg. | ||
| 31 | TOLFENEXT | INJECTABLE | 100 ML | updating soon | Each ml contains: tolfenamic acid 40 mg. |
GET IN TOUCH
Receive the full catalog at your email
Get NEXTROMM products catalog delivered to your email. Share your email below: